## JBHT: J.B. Hunt Transport Services, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.6% below STRENGTH zone (4.0-10.0%); PEG 2.12 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($187.65)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Does Strong Q3 Results, Options Activity and Productivity Progress Change The Bull Case For J.B. Hunt (JBHT)?**
- Source: Sahm | 20251221T170801 | Somewhat-Bullish | Relevance: 100%
- J.B. Hunt Transport Services is gaining investor attention due to strong Q3 2025 results, anticipated Q4 earnings, and active options trading. The company's focus on productivity gains and cost optimization supports earnings, despite an uneven freight market, with expectations of $14.0 billion revenue and $830.2 million earnings by 2028. However, fair value estimates suggest a potential 13% downside from its current price, highlighting diverse analyst opinions and market risks.

**2. RXO (RXO) Valuation Check as Margin Pressures and Negative S&P Outlook Challenge Recovery Prospects**
- Source: Simply Wall Street | 20251222T110953 | Neutral | Relevance: 61%
- RXO (RXO) is facing challenges with margin pressures and a negative S&P outlook, prompting a valuation check. Despite recent share price declines, the company is considered 13% undervalued against a fair value of $15.59 due to its investment in AI-powered digital freight matching technology, which is expected to drive future margin and EBITDA growth. However, persistent automotive sector weakness and freight market softness could delay this recovery and challenge the optimistic AI-driven earnings narrative.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Stifel | $172 | $147 | +17% |
| 2025-12-11 | Deutsche Bank | $227 | $133 | +71% |
| 2025-12-08 | Morgan Stanley | $165 | $150 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Stifel | main | Hold |
| 2025-12-11 | Deutsche Bank | up | Buy |
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.00M) |
| Sells | 14 ($2.90M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (-3.3%)
- Blackrock Inc.: 6.5% (-5.2%)
- JPMORGAN CHASE & CO: 5.6% (+136.9%)
- State Street Corpora: 4.2% (-2.6%)
- Janus Henderson Grou: 4.0% (+11.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.6% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +33%) could attract flows.
- New product launch cycle could drive revenue acceleration.

### Fundamentals

PEG ratio 2.12 elevated, pricing in significant growth expectations. Analyst sentiment positive (3 raises, avg +33%). Insider selling cluster ($2.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.1B |
| Beta | 1.28 |
| 52W Range | $122.79 - $204.43 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.12 |
| Forward P/E | 27.9 |
| Current P/E | 32.9 |
| YoY Growth | 18.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 8.1% to 2.6% (-5.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >4.0% for momentum thesis). MRS_5 (-1.5%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.6% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.56% (CS: 78) | Neutral |
| RSI_14 | 68.4 | Neutral |
| MACD Histogram | -0.30 | Bearish |
| vs SMA20 | 1.036x | Above |
| vs SMA50 | 1.126x | Above |
| vs SMA200 | 1.312x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $197.03
- **Stop Loss:** $187.65 (4.8% risk)
- **Target:** $206.41 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 95
- **Position Value:** $18,717.85
- **Portfolio %:** 18.72%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-15 (Est: $1.77)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.46 | $1.76 | +20.7% |
| 2025Q2 | $1.30 | $1.31 | +0.5% |
| 2025Q1 | $1.14 | $1.17 | +2.2% |
| 2024Q4 | $1.62 | $1.53 | -5.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*